Zai Lab (HKSE:09688) FCF Yield % : -7.70 (As of Dec. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zai Lab FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Zai Lab's Trailing 12-Month Free Cash Flow is HK$-1,708 Mil, and Market Cap is HK$22,082 Mil. Therefore, Zai Lab's FCF Yield % for today is -7.70%.

The historical rank and industry rank for Zai Lab's FCF Yield % or its related term are showing as below:

HKSE:09688' s FCF Yield % Range Over the Past 10 Years
Min: -19.99 Med: -10.44 Max: -0.69
Current: -7.7

During the past 9 years, the highest FCF Yield % of Zai Lab was -0.69%. The lowest was -19.99%. And the median was -10.44%.

HKSE:09688's FCF Yield % is ranked better than
61.31% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs HKSE:09688: -7.70

Zai Lab's FCF Margin % for the quarter that ended in Sep. 2024 was -55.45%.

Zai Lab FCF Yield % Historical Data

The historical data trend for Zai Lab's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab FCF Yield % Chart

Zai Lab Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-1.93

-9.17

-12.94

-7.72

Zai Lab Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															-9.73	-2.36	-25.70	-10.23	-9.44

Competitive Comparison of Zai Lab's FCF Yield %

For the Biotechnology subindustry, Zai Lab's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zai Lab's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zai Lab's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Zai Lab's FCF Yield % falls into.

Zai Lab FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Zai Lab's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1614.044	/	20903.1385
	=	-7.72%

Zai Lab's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-441.796	*	4	/	18722.45112
	=	-9.44%

Zai Lab FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Zai Lab FCF Yield % Related Terms

Thank you for viewing the detailed overview of Zai Lab's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zai Lab Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (HKSE:09688) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ZLAB:USA ZLAB:Mexico 1ZLB:Germany

Address

4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210

Website

https://www.zailaboratory.com

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Wellington Management Group Llp	2102 Investment manager
Ubs Group Ag	2201 Interest of corporation controlled by you
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Janus Henderson Group Plc	2102 Investment manager
Du Ying	2101 Beneficial owner
Qiming Corporate Gp Iv, Ltd.
Qiming Gp Iv, L.p.
Qiming Venture Partners Iv, L.p.
Qm11 Limited
Fmr Llc	2201 Interest of corporation controlled by you
Invesco Advisers, Inc.	2102 Investment manager
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Baillie Gifford & Co	2102 Investment manager
Citigroup Inc.	2502 Approved lending agent

Zai Lab Headlines

No Headlines